Patient P-01535
Synthetic patientNBL-101 · Day 113 · 65–74 · M · baseline S19Steering view · 3DOpen companion preview
Therapy response
Declining
Tolerance
Improving
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
7%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S19
- Day 18 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 18.
Primary contributors, last 14 days
- GI instability-26
- Nutritional resilience+18
- Inflammatory activity-11
- Treatment adherence-5
- Toxicity-5
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion8.8/100
worsening · +4.2 vs previous 14 d
Toxicity
Blood12.4/100
stable · +0.0 vs previous 14 d
Sleep quality
Wearable68/100
stable · -2.5 vs previous 14 d
Energy level
Daily log7.6/10
stable · -0.3 vs previous 14 d
Stress level
Daily log3.5/10
stable · +0.1 vs previous 14 d
Steps
Wearable2,859
worsening · -243 vs previous 14 d
Adherence
Companion89.5 %
stable · -0.2 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards restoration · 92 from the failing basin, 12 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
- More simple carbsGI -3.3 next day on high-intake days · n 16
Would not help
- Keep histamine lowGI +7.1 next day on high-intake days · n 27
- Keep alcohol lowGI +4.5 next day on high-intake days · n 19
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Histamine load+7.1detractor · 95%
- Alcohol+4.5detractor · 77%
- Simple carbohydrates-3.3supporter · 59%
- Dietary fat load+2.3no signal · 33%
- Spicy / capsaicin+1.7no signal · 26%
- Insoluble fibre-1.6no signal · 24%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Mucosal barrier integrity ↓30
- DNAFUT2 non-secretor lowers mucosal fucosylation
- Inflammatory signalling ↓20
- MicrobiomeBacteroides fragilis expansion
- Autonomic recovery ↑20
- Wearable2,859 steps/day
DNA
Fictional pharmacogenomic panel
- FUT2 rs601338 AA (non-secretor)Reduced mucosal fucosylation
- CYP2D6 Intermediate metabolizerExpected exposure
Microbiome
Shannon diversity 4.3 · butyrate capacity 60/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumLow
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 45 ms
- Sleep
- 7.9 h
- Steps
- 3,306
- Resting HR
- 71 bpm
Daily log: GI score 9, nutritional resilience 73, adherence 90.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- A 15-minute walk after lunch
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.